ArticleFrontiers in oncology2024

Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer.

Sathya Neelature Sriramareddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.